{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-081155","form_type":"8-K","ticker":"TRAW","cik":"0001130598","company_name":"Traws Pharma, Inc.","filed_at":"2024-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.246172+00:00","generated_at":"2026-05-31T18:56:51.782927+00:00","sec_items":["4.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"Traws Pharma appoints KPMG as new independent auditor, replacing Ernst & Young","bullets":["On July 16, 2024, Traws Pharma's Audit Committee engaged KPMG as its new independent registered public accounting firm for the year ending December 31, 2024.","During the fiscal years 2022 and 2023 and interim period through July 16, 2024, the company did not consult KPMG on accounting principles or any disagreements/reportable events.","Ernst & Young provided a letter to the SEC dated July 19, 2024, agreeing with the company's statements regarding the auditor change."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-081155","json":"https://secwatch.observer/filing/0001104659-24-081155.json","markdown":"https://secwatch.observer/filing/0001104659-24-081155.md","text":"https://secwatch.observer/filing/0001104659-24-081155.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/0001104659-24-081155-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1130598/000110465924081155/tm2419807d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:56:51.782927+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}